Previous Article | Next Article 
Journal of Virology, December 2001, p. 11907-11912, Vol. 75, No. 23
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11907-11912.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Murine Leukemia Virus Proviral Insertions between
the N-ras and unr Genes in B-Cell Lymphoma DNA
Affect the Expression of N-ras Only
Javier
Martín-Hernández,1
Annette Balle
Sørensen,1 and
Finn Skou
Pedersen1,2,*
Department of Molecular and Structural
Biology1 and Department of Medical
Microbiology and Immunology,2 University of
Aarhus, DK-8000 Aarhus C, Denmark
Received 18 April 2001/Accepted 5 September 2001
 |
ABSTRACT |
Akv1-99, a variant of Akv murine leukemia virus, induces
B-cell lymphomas with nearly 100% incidence and a mean latency period of 12 months after injection into newborn NMRI mice. PCR amplification and sequence analyses of DNA flanking integrated proviruses revealed proviral insertion into the N-ras/unr (upstream of
N-ras) locus in 2 out of 13 B-cell lymphomas, both of which
appeared clonal by Southern blotting analysis. These two tumors showed
increased expression levels of N-ras by Northern blotting,
as did a third tumor shown by reverse transcriptase PCR to have
a nonclonal provirus integration located in the same area. However, no
significant changes in expression were observed when using a specific
probe for the unr gene. All proviruses were integrated in
the same transcriptional orientation as unr and
N-ras genes. By promoter insertion, the two Akv1-99
proviruses integrated between exon
1 and exon 1 of N-ras
gave rise to two different spliced products, whereas the provirus
integrated into unr used only an exon skipping pattern. The
absence of mutations of the N-ras codons 12, 13, 18, and 61 suggests that activation of the proto-oncogene is exclusively due to
overexpression by retroviral promoter insertion, and furthermore, Northern blot analyses indicate that the expression of unr
is unaffected by N-ras overexpression even in the case
where the unr gene itself is the target of proviral
insertion. Thus, altogether our findings indicate that overexpression
of N-ras plays a role in development of murine leukemia
virus-induced B-cell lymphomas, leaving the expression of the tightly
linked unr gene unaltered.
 |
TEXT |
Akv is an ecotropic
nonacutely transforming murine leukemia virus (MLV) derived from the
AKR mouse strain. Akv, as well as an Akv mutant (Akv1-99) with only one
copy of the 99-bp transcriptional enhancer, induces B-cell lymphomas
with latency periods of about 12 months when inoculated into newborn
NMRI mice (20). As for other nonacutely transforming
retroviruses lacking internal oncogenes, one of the
major steps in induction of disease involves provirus integration near
a cellular proto-oncogene of an appropriate target cell that results in
aberrant expression of the gene (17, 28). During the last
few decades, analyses of provirus integration sites in DNA from
MLV-induced tumors have identified far more than 100 genes or loci
which are thought to play critical roles in the progress of disease
(reviewed in reference 24).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Diagram showing the locations and orientations of the
three Akv1-99 insertions detected in tumor 3 (before nucleotide
335), tumor 9 (before nucleotide 1062), and tumor 11 (before
nucleotide 1085) in this study (gray arrowheads) as well as previously
reported insertions, SL3-3 (before nucleotide 668) and VST27016G1
(before nucleotide 1084) (11, 25) (black and white
arrowheads, respectively). All five proviruses are inserted within an
area of about 800 bp. Arrows indicate orientations of transcription of
unr and N-ras. Shown below are the probes made by
PCR that were used for Southern and Northern hybridizations. Probe A
(915 bp) covers the very last untranslated 3' region of unr
and the first two N-ras exons (positions 382 to 1297); probe
B (646 bp) comprises the first two N-ras exons (positions
651 to 1297); probe C (369 bp) contains the last 3' exon of
unr (positions 1 to 369). Positions indicated correspond to
the GenBank sequence with accession no. L19607. ut, untranslated.
|
|
The ras family genes Kirsten (K-ras) and Harvey
(H-ras) have previously been reported to be targeted by MLVs
in a myeloid and a thymic tumor cell line, respectively, inducing
disruption of the normal gene properties (10, 12, 27),
while two cases of murine B-cell lymphoma have shown MLV provirus
insertion in N-ras (11, 26). These
proto-oncogenes, which participate in normal cellular growth signaling,
have also been reported to be activated by single point mutations
(1). Thus, N-ras mutations can be found in a
variety of human tumor types (2), including hematological
malignancies such as acute myeloid and lymphoblastic leukemias
(16, 21). The clear involvement of N-ras in
disease has led to extensive investigations concerning regulatory
elements (23), locus organization (13), and
transcriptional regulation (15) associated with the
discovery of a 5' closely linked gene, unr (upstream of
N-ras) (7, 14, 22). The ubiquitous expression of N-ras and unr, besides the same
transcriptional orientation of the genes, has motivated several studies
regarding possible regulation of the N-ras expression by
unr or vice versa (3, 4, 19). However, no
mechanism of expression modulation between N-ras and
unr has been clearly detected. unr contains
internal repeats with homology to cold shock domains (8),
and despite previously reported analyses concerning structure (4,
13), nucleic acid-binding properties (9), and
genomic organization (3), the function of the gene remains
unclear. Homozygous unr
/
mice have not been obtained,
though, which suggests an embryonic lethal effect of the deletion
(3).
During our search for critical genes involved in development of
Akv1-99-induced B-cell lymphomas, we discovered three cases of provirus
integrations into the N-ras/unr locus. All three tumors showed increased N-ras expression, while the expression of
unr was unaltered. The three integrated proviruses had the
same orientation of transcription as N-ras, as did two
previously reported cases of MLV insertions at this site in lymphomas
(11, 26), and all five integrations were located in a
narrow area of about 800 bp. This region covers the very 3' end of
unr and the noncoding exon (exon
1) and first intron of
N-ras and has been shown previously to be of importance for
regulation of N-ras expression (15). Analogous
regions have been shown elsewhere to be susceptible to integration of
proviruses oriented cotranscriptionally in the targeted
K-ras and H-ras genes (12, 27).
Therefore, this area in general appears to be particularly susceptible
to retroviral insertion in MLV-induced lymphomas, suggesting this
region to be of importance for the induction-progression of
disease development. Altogether, our findings indicate that
overexpression of N-ras plays a role in development of
MLV-induced B-cell lymphomas, leaving the expression of the tightly
linked unr gene unaltered.
Amplification and sequence analyses of DNA flanking integrated
proviruses.
In order to identify genes involved in tumor
development, we isolated proviral flanking sequences from tumors
induced by the B-lymphomagenic virus Akv1-99. A simple two-step PCR
method, which has previously been described as an efficient technique
for isolation and sequencing of provirus-host junctions (25,
26), was employed. By this, a total of 30 proviral flanking
sequences were obtained from 13 independent Akv1-99-induced lymphomas,
all of which had been widely analyzed earlier in regard to morphology
and molecular characterization (20). Following
amplification and sequencing of proviral flanks, database search
comparisons were performed, revealing that 12 of 30 isolated sequences
were homologous to known sequences. Moreover, two of these sequences,
amplified from tumors 3 and 11, showed homology to the locus
N-ras/unr, thus suggesting this locus to be a preferred
target in MLV-induced B-cell lymphoma development.
Clonal proviral integrations into the N-ras/unr
locus.
The two perfect homologies to the N-ras/unr
locus sequence were obtained from DNA from tumors 3 and 11. Both
proviral integrations were verified by PCR using N-ras and
provirus-specific primers (data not shown), and results confirmed that
the sites of integration were in the very 5' end of the
N-ras locus, namely, 835 and 85 bp upstream of exon 1, respectively, and that the transcriptional orientations of the two
proviruses were the same as those of the N-ras and
unr genes (Fig. 1). To
investigate the clonality of the integrated proviruses (in the
N-ras/unr locus), Southern blotting was performed as
described previously (26) on
HindIII-digested tumor DNAs (Fig.
2), with an N-ras/unr probe
(Fig. 1, probe A), and in both cases a rearranged fragment of the
expected size (17 kb) was observed, indicating that the two proviruses
were clonally integrated. In addition, the absence of rearrangements in
the other tumor DNAs indicated that no additional clonal Akv1-99
provirus integrations in the N-ras/unr locus were present in
the remaining 10 lymphoma samples analyzed (Fig. 2).

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 2.
Southern blot analysis of
HindIII-digested tumor DNAs from Akv1-99 tumors
hybridized with a mouse N-ras probe (probe A), shown in Fig.
1. A rearranged fragment of about 17 kb in tumors 3 and 11 can be
detected, while no arrangements are seen in the remaining tumors.
Arrowheads indicate positions of the germ line (8 kb) and rearranged
fragments (17 kb).
|
|
Expression levels of the mouse N-ras and
unr genes.
To examine if the integrated proviruses
affected the expression of N-ras, Northern blot analyses
were performed (Fig. 3) using the three
different probes shown in Fig. 1. Previous reports have shown three
species of N-ras mRNA of 5.0, 2.4, and 1.3 kb, respectively, where the 2.4-kb transcript signal has been reported to be weak, and
the difference in sizes reflects usage of different poly(A) sites all
downstream of the coding region (5, 18, 19). In agreement
with these observations, two predominant transcripts of 5.0 and 1.3 kb
were observed. Analyses using probe A, which covers the first two
N-ras exons and the very last untranslated 3' region of
unr, showed overexpressed N-ras transcripts in
three tumors, namely, tumor 3, tumor 9, and tumor 11 (Fig. 3A). In all three cases, the 5.0-kb transcript was observed to be overexpressed compared to the remaining tumors and using glyceraldehyde-3-phosphate dehydrogenase as an internal control (Fig. 3D). In addition, the 1.3-kb transcript was overexpressed in both tumor 9 and tumor 11, but
the ratio between the intensities of the 5.0- and 1.3-kb transcripts
appeared to be inversely proportional in the two tumors (Fig. 3A).

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot hybridizations of RNA (23 µg) extracted
from 11 independent tumors induced by Akv1-99. Hybridization was
performed using either probe A (A), probe B (B), or probe C (C) (probes
are shown in Fig. 1). Arrowheads indicate N-ras mRNA sizes.
Tumor numbers are given on top of each lane. Hybridization with
glyceraldehyde-3-phosphate dehydrogenase was used as an
internal control (D).
|
|
Rehybridization of the filter with probe B, covering only
N-
ras exons, presented a similar pattern of increased
expression
for N-
ras in the three tumors (Fig.
3B). In
contrast, however,
a probe containing the last 3' exon of
unr (probe C) showed no
major differences in expression
levels of
unr in the 11 examined
tumors (Fig.
3C),
indicating that the expression of the
unr gene
was not
affected by the integrated proviruses, nor by overexpression
of
N-
ras. The overexpression of N-
ras observed for
tumor 9 was
clarified by later experiments (see
below).
To this point, we have identified a clonal integration into the
unr gene in tumor 3 which did not affect expression of the
target gene but caused an altered expression of the downstream
N-
ras gene. This led us to investigate the character of the
unr transcripts in tumor 3. PCR analyses of tumor cDNA were
performed
using
unr-specific primers (primer c or d [Fig.
4]) and a primer
matching the oligo(dT)
primer tag (primer e [Fig.
4]), amplifying
the very 3' region of
possible
unr-containing transcripts. Two
products for each
primer combination were obtained, and sequencing
analyses demonstrated
that the smaller fragments (280 and 220
bp) corresponded to the normal
unr transcript, while the larger
ones (620 and 560 bp) were
consistent with transcripts ending
in the integrated proviruses using
the normal viral poly(A) signal.
Two resulting products are in
accordance with one allele containing
a provirus while the other lacks
that integration. However, the
difference in size is not sufficient
under our conditions of Northern
blot analysis (Fig.
3C) to definitely
establish whether the observed
5.0-kb band comprises both transcripts.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
RT-PCR analyses of tumor 3. (A) Representation of the
provirus integrated into the unr gene. Primer c
or d (positions 217 to 242 or 269 to 290, respectively;
positions correspond to the GenBank sequence with the accession no.
L19607), together with primer e, was used for the
amplification of possible unr transcripts. Primer
e hybridizes to the 5' end of a poly(T) primer
[5'-GGGTCTAGAGCTCGAGTCAC(T)16V-3' (V = A/G/C)] which was used for reverse transcription. The figure is not
drawn to scale. ut, untranslated; LTR, long terminal repeat. (B) PCR
amplifications of the reverse-transcribed cDNA. Amplifications were
done twice on the same preparation of cDNA. Primers used are indicated
on top of each lane. Sizes of observed fragments are indicated at the
right. M, molecular size markers (1,000, 900, 800, 700, 600, 500, 400, 300, and 200 bp, top to bottom, respectively).
|
|
Taken together, these Northern blotting experiments revealed
overexpression of N-
ras in lymphomas 3, 9, and 11, while
unr expression levels seemed to be unaffected by the
integrated
provirus.
Point mutation and splicing analyses of the N-ras/unr
locus.
Point mutations and increased expression have been reported
previously to induce disruption in the normal function of
N-ras (1). In order to investigate possible
mutagenesis in significant codons, including codons 12, 13, 18, and 61, mutations of which in the human gene are well known to be responsible
for the activation of the N-ras oncogene (1,
6), reverse transcriptase PCR (RT-PCR) and cDNA sequence
analyses for all tumor samples were performed. These analyses, which
comprised codons 1 to 66 of the N-ras protein, revealed no alterations
(data not shown), indicating that, in tumors 3, 9, and 11, the
proto-oncogene is activated solely by overexpression. The analyses of
the sequences of the amplified cDNA in tumor 9 showed that also in this
case a provirus had inserted into N-ras, and it was located
at the downstream end of intron 1 (Fig. 1), thus being consistent with
the increased expression level of N-ras observed for this
tumor (see above).
Furthermore, the RT-PCR analyses revealed that two different patterns
of splicing were followed in tumors 9 and 11, while
a single pathway
was observed in tumor 3 (Fig.
5). In all
cases,
splicing was carried out using cryptic splice donor sites.
RT-PCR
of tumor 3 using a provirus-specific primer (primer a [Fig.
5])
and a primer located at the 5' end of N-
ras exon 2 (primer b [Fig.
5]) followed by sequence analyses showed skipping of
the last
90 nucleotides of the last
unr exon as well as of
the N-
ras noncoding
exon

1. Two different mRNAs were
observed when analyzing tumor
9 using the same primer set; in one case,
all the intron fragment
located between the provirus and the first
coding exon (exon 1)
was present, while in a second case the majority
of that intron
was spliced out. A similar pattern was observed in tumor
11, in
which the same functional, cryptic splice donor site located in
the first intron was used, together with the normal splice acceptor
site at exon 1 of N-
ras (Fig.
5). The role of these
different
splice products, e.g., whether they affect the differential
usage
of the poly(A) sites, cannot be determined.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Splicing of N-ras. In tumor 3, exon 1 is
skipped during RNA processing (cryptic splice donor and normal exon 1 splice acceptor sites, located at positions 357 and 1170, respectively;
positions correspond to the GenBank sequence with accession no.
L19607). In tumors 9 and 11, two mRNAs are generated. Splice product A
contains the intron fragment from the provirus to exon 1, and splice
product B contains a minor intron 1 fragment (cryptic splice donor and
normal exon 1 splice acceptor sites, at positions 1097 and 1170, respectively; positions correspond to the GenBank sequence with
accession no. L19607). Provirus-specific primer a
(5'-TCCGAATCGTGGTCTCGCTGATCCTTGG-3') and N-ras
primer b (positions 428 to 405; GenBank accession no. X13664) were used
in all cases. Arrowheads indicate the locations of the proviruses and
proviral sequences. ut, untranslated.
|
|
Conclusions.
Herein, we have amplified and analyzed flanking
sequences of integrated proviruses in lymphomas induced by the Akv1-99
MLV and identified three integrations in the N-ras/unr
locus. All three proviruses were shown to be located in a region
previously reported to contain a provirus integration in an SL3-3
MLV-induced tumor (26) and in an AKXD mouse tumor
(11). Expression analyses showed an increase of
N-ras RNA levels in the three tumors containing a proviral
insertion in this locus, despite the fact that only two of them seemed
to be clonal as assessed by Southern blotting analysis. The tumors
found to harbor the integration were classified earlier as B-cell
tumors (tumors 3 and 11) and mixed T-cell-B-cell tumors (tumor 9)
(20), while the other, previously described proviral
N-ras integrations were classified as B-cell tumors
(11, 26; unpublished results). This altogether suggests
that N-ras is targeted by MLV primarily in B-cell tumors.
Sequencing analyses of DNA from all tumors showed no point mutations in
any of the N-
ras codons critical for human oncogenic
activation by point mutations, indicating that activation is
exclusively
a consequence of the retroviral integration. Thus, in
summary,
we have shown that N-
ras is activated by promoter
insertion in
3 out of 13 independent Akv1-99-induced tumors, suggesting
a tight
relationship between MLV-induced B-cell lymphoma development
and
N-
ras proviral integration. Moreover, we have also shown
that
unr expression seems unaffected by the activation of
N-
ras.
 |
ACKNOWLEDGMENTS |
This project was supported by the Danish Cancer Research Fund, the
Novo Nordic Foundation, the Danish Cancer Society, the Karen Elise
Jensen Foundation, the Danish Natural Sciences and Medical Research
Councils, DNA Technology A/S, and Universidad Autónoma de Madrid.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular and Structural Biology, University of Aarhus, C. F. Møllers Allé Bldg. 130, DK-8000 Aarhus C, Denmark. Phone: 45 8942 3188. Fax: 45 8619 6500. E-mail: fsp{at}mbio.aau.dk.
 |
REFERENCES |
| 1.
|
Barbacid, M.
1987.
ras genes.
Annu. Rev. Biochem.
56:779-827[CrossRef][Medline].
|
| 2.
|
Bos, J. L.
1989.
ras oncogenes in human cancer: a review.
Cancer Res.
49:4682-4689[Abstract/Free Full Text]. (Erratum, 50:1352, 1990.)
|
| 3.
|
Boussadia, O.,
F. Amiot,
S. Cases,
G. Triqueneaux,
H. Jacquemin-Sablon, and F. Dautry.
1997.
Transcription of unr (upstream of N-ras) down-modulates N-ras expression in vivo.
FEBS Lett.
420:20-24[CrossRef][Medline].
|
| 4.
|
Boussadia, O.,
H. Jacquemin-Sablon, and F. Dautry.
1993.
Exon skipping in the expression of the gene immediately upstream of N-ras (unr/NRU).
Biochim. Biophys. Acta
1172:64-72[Medline].
|
| 5.
|
Chang, H. Y.,
I. Guerrero,
R. Lake,
A. Pellicer, and P. D'Eustachio.
1987.
Mouse N-ras genes: organization of the functional locus and of a truncated cDNA-like pseudogene.
Oncogene Res.
1:129-136[Medline].
|
| 6.
|
Demunter, A.,
M. R. Ahmadian,
L. Libbrecht,
M. Stas,
M. Baens,
K. Scheffzek,
H. Degreef,
C. De Wolf-Peeters, and J. J. van Den Oord.
2001.
A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Cancer Res.
61:4916-4922[Abstract/Free Full Text].
|
| 7.
|
Doniger, J., and J. A. DiPaolo.
1988.
Coordinate N-ras mRNA up-regulation with mutational activation in tumorigenic guinea pig cells.
Nucleic Acids Res.
16:969-980[Abstract/Free Full Text].
|
| 8.
|
Doniger, J.,
D. Landsman,
M. A. Gonda, and G. Wistow.
1992.
The product of unr, the highly conserved gene upstream of N-ras, contains multiple repeats similar to the cold-shock domain (CSD), a putative DNA-binding motif.
New Biol.
4:389-395[Medline].
|
| 9.
|
Ferrer, N.,
A. Garcia-Espana,
M. Jeffers, and A. Pellicer.
1999.
The unr gene: evolutionary considerations and nucleic acid-binding properties of its long isoform product.
DNA Cell Biol.
18:209-218[CrossRef][Medline].
|
| 10.
|
George, D. L.,
B. Glick,
S. Trusko, and N. Freeman.
1986.
Enhanced c-Ki-ras expression associated with Friend virus integration in a bone marrow-derived mouse cell line.
Proc. Natl. Acad. Sci. USA
83:1651-1655[Abstract/Free Full Text].
|
| 11.
|
Hansen, G. M.,
D. Skapura, and M. J. Justice.
2000.
Genetic profile of insertion mutations in mouse leukemias and lymphomas.
Genome Res.
10:237-243[Abstract/Free Full Text].
|
| 12.
|
Ihle, J. N.,
B. Smith-White,
B. Sisson,
D. Parker,
D. G. Blair,
A. Schultz,
C. Kozak,
R. D. Lunsford,
D. Askew,
Y. Weinstein, and R. J. Isfort.
1989.
Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia.
J. Virol.
63:2959-2966[Abstract/Free Full Text].
|
| 13.
|
Jacquemin-Sablon, H., and F. Dautry.
1992.
Organization of the unr/N-ras locus: characterization of the promoter region of the human unr gene.
Nucleic Acids Res.
20:6355-6361[Abstract/Free Full Text].
|
| 14.
|
Jeffers, M.,
R. Paciucci, and A. Pellicer.
1990.
Characterization of unr; a gene closely linked to N-ras.
Nucleic Acids Res.
18:4891-4899.
|
| 15.
|
Jeffers, M., and A. Pellicer.
1992.
Multiple intragenic elements regulate the expression of the murine N-ras gene.
Oncogene
7:2115-2123[Medline].
|
| 16.
|
Kiyoi, H.,
T. Naoe,
Y. Nakano,
S. Yokota,
S. Minami,
S. Miyawaki,
N. Asou,
K. Kuriyama,
I. Jinnai,
C. Shimazaki,
H. Akiyama,
K. Saito,
H. Oh,
T. Motoji,
E. Omoto,
H. Saito,
R. Ohno, and R. Ueda.
1999.
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Blood
93:3074-3080[Abstract/Free Full Text].
|
| 17.
|
Kung, H. J.,
C. Boerkoel, and T. H. Carter.
1991.
Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation.
Curr. Top. Microbiol. Immunol.
171:1-25[Medline].
|
| 18.
|
Leon, J.,
I. Guerrero, and A. Pellicer.
1987.
Differential expression of the ras gene family in mice.
Mol. Cell. Biol.
7:1535-1540[Abstract/Free Full Text].
|
| 19.
|
Lopez-Fernandez, L. A.,
D. M. Lopez-Alanon, and J. del Mazo.
1995.
Different developmental pattern of N-ras and unr gene expression in mouse gametogenic and somatic tissues.
Biochim. Biophys. Acta
1263:10-16[Medline].
|
| 20.
|
Lovmand, J.,
A. B. Sorensen,
J. Schmidt,
M. Ostergaard,
A. Luz, and F. S. Pedersen.
1998.
B-cell lymphoma induction by Akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
J. Virol.
72:5745-5756[Abstract/Free Full Text].
|
| 21.
|
Nakao, M.,
J. W. Janssen,
T. Seriu, and C. R. Bartram.
2000.
Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology.
Leukemia
14:312-315[CrossRef][Medline].
|
| 22.
|
Nicolaiew, N.,
G. Triqueneaux, and F. Dautry.
1991.
Organization of the human N-ras locus: characterization of a gene located immediately upstream of N-ras.
Oncogene
6:721-730[Medline].
|
| 23.
|
Paciucci, R., and A. Pellicer.
1991.
Dissection of the mouse N-ras gene upstream regulatory sequences and identification of the promoter and a negative regulatory element.
Mol. Cell. Biol.
11:1334-1343[Abstract/Free Full Text].
|
| 24.
|
Rosenberg, N., and P. Jolicoeur.
1997.
Retroviral pathogenesis, p. 475-586.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 25.
|
Sørensen, A. B.,
M. Duch,
P. Jørgensen, and F. S. Pedersen.
1993.
Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method.
J. Virol.
67:7118-7124[Abstract/Free Full Text].
|
| 26.
|
Sørensen, A. B.,
M. Duch,
H. W. Amtoft,
P. Jørgensen, and F. S. Pedersen.
1996.
Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3.
J. Virol.
70:4063-4070[Abstract].
|
| 27.
|
Trusko, S. P.,
E. K. Hoffman, and D. L. George.
1989.
Transcriptional activation of cKi-ras proto-oncogene resulting from retroviral promoter insertion.
Nucleic Acids Res.
17:9259-9265[Abstract/Free Full Text].
|
| 28.
|
Tsichlis, P. N., and P. A. Lazo.
1991.
Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses.
Curr. Top. Microbiol. Immunol.
171:95-171[Medline].
|
Journal of Virology, December 2001, p. 11907-11912, Vol. 75, No. 23
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11907-11912.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Landais, S., Quantin, R., Rassart, E.
(2005). Radiation Leukemia Virus Common Integration at the Kis2 Locus: Simultaneous Overexpression of a Novel Noncoding RNA and of the Proximal Phf6 Gene. J. Virol.
79: 11443-11456
[Abstract]
[Full Text]
-
Johnson, C., Lobelle-Rich, P. A., Puetter, A., Levy, L. S.
(2005). Substitution of Feline Leukemia Virus Long Terminal Repeat Sequences into Murine Leukemia Virus Alters the Pattern of Insertional Activation and Identifies New Common Insertion Sites. J. Virol.
79: 57-66
[Abstract]
[Full Text]
-
Lin, Z., Crockett, D. K., Jenson, S. D., Lim, M. S., Elenitoba-Johnson, K. S. J.
(2004). Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells. Mol. Cell. Proteomics
3: 820-833
[Abstract]
[Full Text]